Great Point Partners LLC Portfolio Holdings

Great Point Partners LLC

  • $152 Million
  • Q4 2024

Great Point Partners LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $152 Million distributed in 26 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ionis Pharmaceuticals Inc with a value of $17.7M, Cytokinetics Inc with a value of $16.9M, Kal Vista Pharmaceuticals, Inc. with a value of $15.1M, Viridian Therapeutics, Inc.\De with a value of $14.4M, and Pliant Therapeutics, Inc. with a value of $13.9M.

Examining the 13F form we can see an decrease of $64.6M in the current position value, from $216M to 152M.

Great Point Partners LLC is based out at Greenwich, CT

Below you can find more details about Great Point Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $152 Million
Healthcare: $149 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$4.59B
$17.7 Million 11.64% of portfolio
505,007
Q4 2024 Added 98.04%
$4.73B
$16.9 Million 11.17% of portfolio
360,000
Q4 2024 Added 13.92%
$247M
$15.1 Million 9.98% of portfolio
1,787,003
Q4 2024 Added 37.51%
$649M
$14.4 Million 9.48% of portfolio
750,000
Q3 2024 Added 50.0%
$150M
$13.9 Million 9.16% of portfolio
1,055,000
Q4 2024 Reduced 44.77%
$1.69B
$11 Million 7.24% of portfolio
860,000
Q4 2024 Reduced 35.15%
$785M
$9.89 Million 6.52% of portfolio
895,524
Q4 2024 Reduced 23.46%
$2.47B
$9.61 Million 6.34% of portfolio
245,272
Q4 2024 New
$9.33M
$8.67 Million 5.72% of portfolio
10,980,000
Q4 2024 Added 28.29%
$177M
$7.07 Million 4.66% of portfolio
3,009,392
Q4 2024 Added 7.02%
$2.17B
$6.65 Million 4.38% of portfolio
158,092
Q4 2024 Reduced 36.76%
$163M
$4.69 Million 3.09% of portfolio
826,751
Q4 2024 Reduced 13.88%
$12.9M
$4.64 Million 3.06% of portfolio
4,683,711
Q4 2024 Reduced 32.46%
$356M
$4.03 Million 2.65% of portfolio
1,150,000
Q4 2024 New
$182M
$2.97 Million 1.96% of portfolio
621,894
Q4 2024 New
$0
$2.46 Million 1.62% of portfolio
2,645,128
Q4 2024 Reduced 5.22%
Upstream Bio Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Abivax Sa
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 22.56%
Oruka Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 55.54%
Optinose Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Neurogene Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 55.91%
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 19.81%
Helix Acquisition Corp Ii
-
$0 0.0% of portfolio
-
Q1 2024 New
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 63.72%
Zura Bio LTD
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 2.86%

Summary

  • Portfolio
  • No. of Stocks 26
  • Current Value $152 Million
  • Prior Value $216 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 5 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email